ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

This adverse event was reported 668 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY:

# Drug Count
0 ADALIMUMAB 555
1 METHOTREXATE SODIUM 534
2 TOCILIZUMAB 526
3 DICLOFENAC SODIUM 525
4 DICLOFENAC 521
5 METHOTREXATE 518
6 ETANERCEPT 508
7 ADALIMUMAB-ADAZ 504
8 DESOXIMETASONE 503
9 FOLIC ACID 503
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRICLOSAN 84 0.1456
1 TRIPROLIDINE HYDROCHLORIDE 19 0.0974
2 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 49 0.0745
3 CLEAR MINT, GEL TOOTHPASTE 70 0.0638
4 SODIUM FLUORIDE F18 70 0.0633
5 SODIUM FLUORIDE F-18 70 0.0632
6 CAFFEINE CITRATE 145 0.0621
7 DICLOFENAC POTASSIUM TABLETS 381 0.0439
8 GOLIMUMAB 493 0.0391
9 BACITRACIN ZINC AND POLYMYXIN B SULFATE 4 0.0360
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 25 0.0363
1 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 127 0.0146
2 Provitamin D2 Compound [EPC] 319 0.0107
3 Interleukin-17A Antagonist [EPC] 372 0.0100
4 Endoglycosidase [EPC] 11 0.0059
5 Aminosalicylate [EPC] 539 0.0053
6 Histamine-1 Receptor Antagonist [EPC] 358 0.0042
7 Tetracycline-class Drug [EPC] 300 0.0042
8 Antirheumatic Agent [EPC] 438 0.0041
9 Interleukin-12 Antagonist [EPC] 414 0.0040
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY